no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A golden garden for people with rare dementias
|
Morgan, Jules |
|
|
22 |
8 |
p. 660 |
article |
2 |
Autosomal dominant cerebellar ataxias: new genes and progress towards treatments
|
Coarelli, Giulia |
|
|
22 |
8 |
p. 735-749 |
article |
3 |
Blocking inhibitors of axon growth after spinal cord injury
|
Rong, Limin |
|
|
22 |
8 |
p. 645-646 |
article |
4 |
Climate change and neurology: time to talk and to act
|
Sisodiya, Sanjay M |
|
|
22 |
8 |
p. 656-657 |
article |
5 |
Cognitive outcomes at age 3 years in children with fetal exposure to antiseizure medications (MONEAD study) in the USA: a prospective, observational cohort study
|
Meador, Kimford J |
|
|
22 |
8 |
p. 712-722 |
article |
6 |
Correction to Lancet Neurol 2023; 22: 209–17
|
|
|
|
22 |
8 |
p. e9 |
article |
7 |
Differential diagnosis of suspected multiple sclerosis: an updated consensus approach
|
Solomon, Andrew J |
|
|
22 |
8 |
p. 750-768 |
article |
8 |
Drug resistance in epilepsy
|
Perucca, Emilio |
|
|
22 |
8 |
p. 723-734 |
article |
9 |
Fetal exposure to antiseizure medications: reassurance and concerns
|
Wiznitzer, Max |
|
|
22 |
8 |
p. 648-649 |
article |
10 |
Flora Hammond: teaching us a new song
|
Burton, Adrian |
|
|
22 |
8 |
p. 654 |
article |
11 |
Francesco Brigo
|
|
|
|
22 |
8 |
p. 655 |
article |
12 |
Global burden of meningitis and implications for strategy
|
Kwambana-Adams, Brenda |
|
|
22 |
8 |
p. 646-648 |
article |
13 |
Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
|
|
|
|
22 |
8 |
p. 685-711 |
article |
14 |
Lessons and future directions for GBA1-targeting therapies
|
Gan-Or, Ziv |
|
|
22 |
8 |
p. 644-645 |
article |
15 |
Navigating the challenges of diagnosing multiple sclerosis
|
Chitnis, Tanuja |
|
|
22 |
8 |
p. 649-651 |
article |
16 |
Peru initiates the IMPACT project
|
Lúcar, Miriam G |
|
|
22 |
8 |
p. 653 |
article |
17 |
Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
|
Giladi, Nir |
|
|
22 |
8 |
p. 661-671 |
article |
18 |
Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial
|
Maynard, George |
|
|
22 |
8 |
p. 672-684 |
article |
19 |
The microglial hypothesis of multiple sclerosis
|
Hautecoeur, Patrick |
|
|
22 |
8 |
p. 655 |
article |
20 |
The World Federation of Neurology World Brain Day 2023
|
Grisold, Wolfgang |
|
|
22 |
8 |
p. 652 |
article |
21 |
Thinking, both global and local
|
Stirrups, Robert |
|
|
22 |
8 |
p. 658 |
article |
22 |
Time to get serious about the Global Action Plan on dementia
|
The Lancet Neurology, |
|
|
22 |
8 |
p. 643 |
article |
23 |
To sleep, perchance to dream
|
Stirrups, Robert |
|
|
22 |
8 |
p. 659 |
article |